Javascript must be enabled to continue!
Chronic Stable Angina
View through CrossRef
By definition, chronic stable angina is angina that has been stable with regard to frequency and severity for at least 2 months. Chronic stable angina is the initial manifestation of coronary heart disease in approximately 50% of patients. Typically, this type of angina occurs in the setting of atherosclerotic coronary arterial narrowing, although other causes are possible. This review covers the epidemiology, pathophysiology, initial evaluation, differential diagnosis, management, and treatment of patients with chronic stable angina. Figures show noninvasive testing and the probability of coronary artery disease; diagnosis of patients with suspected ischemic heart disease; probability of severe coronary artery disease; coronary outcomes for high- versus low-intensity statin therapy; optimal medical therapy (OMT) versus OMT and percutaneous coronary intervention for chronic angina; OMT versus percutaneous coronary intervention for stable coronary heart disease; and coronary artery bypass grafting versus percutaneous coronary intervention for diabetes and coronary artery disease. Tables list the grading of angina pectoris by the Canadian Cardiovascular Society classification system, the differential diagnosis of chest pain, conditions promoting myocardial oxygen supply and demand mismatch, the features of typical angina, the classification of chest pain, a comparison of the pretest likelihood of coronary heart disease (CHD) in low-risk and high-risk symptomatic patients, the posttest probability of significant CHD based on pretest probabilities of CHD and normal or abnormal results of noninvasive studies, survival according to risk groups based on Duke treadmill scores, high- and moderate-intensity statin therapy, revascularization to improve survival compared with medical therapy, revascularization to improve symptoms with significant anatomic (≥ 50% left main or ≥ 70% nonleft main coronary artery disease) or physiologic (fractional flow reserve ≤ 0.80) coronary artery stenoses, and questions recommended by an expert panel for patients with chronic stable angina at follow-up visits.
This review contains 7 highly rendered figures, 12 tables, and 109 references.
Title: Chronic Stable Angina
Description:
By definition, chronic stable angina is angina that has been stable with regard to frequency and severity for at least 2 months.
Chronic stable angina is the initial manifestation of coronary heart disease in approximately 50% of patients.
Typically, this type of angina occurs in the setting of atherosclerotic coronary arterial narrowing, although other causes are possible.
This review covers the epidemiology, pathophysiology, initial evaluation, differential diagnosis, management, and treatment of patients with chronic stable angina.
Figures show noninvasive testing and the probability of coronary artery disease; diagnosis of patients with suspected ischemic heart disease; probability of severe coronary artery disease; coronary outcomes for high- versus low-intensity statin therapy; optimal medical therapy (OMT) versus OMT and percutaneous coronary intervention for chronic angina; OMT versus percutaneous coronary intervention for stable coronary heart disease; and coronary artery bypass grafting versus percutaneous coronary intervention for diabetes and coronary artery disease.
Tables list the grading of angina pectoris by the Canadian Cardiovascular Society classification system, the differential diagnosis of chest pain, conditions promoting myocardial oxygen supply and demand mismatch, the features of typical angina, the classification of chest pain, a comparison of the pretest likelihood of coronary heart disease (CHD) in low-risk and high-risk symptomatic patients, the posttest probability of significant CHD based on pretest probabilities of CHD and normal or abnormal results of noninvasive studies, survival according to risk groups based on Duke treadmill scores, high- and moderate-intensity statin therapy, revascularization to improve survival compared with medical therapy, revascularization to improve symptoms with significant anatomic (≥ 50% left main or ≥ 70% nonleft main coronary artery disease) or physiologic (fractional flow reserve ≤ 0.
80) coronary artery stenoses, and questions recommended by an expert panel for patients with chronic stable angina at follow-up visits.
This review contains 7 highly rendered figures, 12 tables, and 109 references.
Related Results
NEW CANDIDATE BIOMARKER FOUND IN UNSTABLE ANGINA PATIENTS BY LC-MS/MS
NEW CANDIDATE BIOMARKER FOUND IN UNSTABLE ANGINA PATIENTS BY LC-MS/MS
Objectives
Coronary heart disease (CHD) is the leading cause of death of adults worldwide, but the traditional related factors cannot explain the whole situations...
Increased Autoantibodies Against Oxidized Low-Density Lipoprotein in Coronary Circulation in Patients with Coronary Spastic Angina
Increased Autoantibodies Against Oxidized Low-Density Lipoprotein in Coronary Circulation in Patients with Coronary Spastic Angina
Oxidized low-density lipoproteins are important in the progression of atherosclerosis. Autoantibodies against malondialdehyde-modified low-density lipoproteins have been reported t...
Abstract 4146122: Potential Protective Roles of Clonal Hematopoiesis of Indeterminate Potential in Angina Pectoris
Abstract 4146122: Potential Protective Roles of Clonal Hematopoiesis of Indeterminate Potential in Angina Pectoris
Introduction:
Clonal hematopoiesis of indeterminate potential (CHIP) poses strong relationship to the occurrence of cardiovascular diseases with the process of aging. I...
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
GW24-e2942 The change of endogenous asymmetric NG, NG-dimethyl-L-arginine in patients with unstable angina pectoris
GW24-e2942 The change of endogenous asymmetric NG, NG-dimethyl-L-arginine in patients with unstable angina pectoris
Objectives
To investigate the change of asymmetric NG, NG-dimethyl-L-arginine (ADMA) and elucidate the possible mechanism of endothelial dysfunction in patients w...
Abstract 9895: Acupuncture Shows Early Efficacy for Pain Reduction in Stable Angina
Abstract 9895: Acupuncture Shows Early Efficacy for Pain Reduction in Stable Angina
Introduction:
Despite a notable 32.7% decline in mortality from ischemic heart disease since 1999, the prevalence of stable angina has not decreased. Up to 30% of patie...
INTRACORONARY AUTOLOGOUS CD34+ STEM CELL THERAPY FOR INTRACTABLE ANGINA
INTRACORONARY AUTOLOGOUS CD34+ STEM CELL THERAPY FOR INTRACTABLE ANGINA
Objectives
A large number of patients with coronary artery disease experience angina that is not suitable for revascularisation and is refractory to conventional ...
Efficacy of Acupuncture as Complementary Therapy for Refractory Angina Pectoris: A Systematic Review
Efficacy of Acupuncture as Complementary Therapy for Refractory Angina Pectoris: A Systematic Review
Introduction: Refractory angina pectoris poses a major public health challenge due to its effects on patients' quality of life, the significant healthcare costs involved, and its i...

